Trisha A. Jenkins Ph.D.
1997 Ph.D. in Neuroscience. University of Melbourne, Department of Medicine, Austin & Repatriation Medical Centre, Victoria, Australia.
1988 B.Sc. Degree in Biochemistry and Pharmacology & Toxicology
Monash University, Victoria, Australia.
2006-present Lecturer, School of Medicine and Dentistry, Queens University Belfast, N. Ireland.
2003-2005 NH&MRC of Australia Howard Florey Centenary Fellow, Howard Florey Institute, University of Melbourne, Victoria, Australia.
2000-2003 Postdoctoral Research Fellow, School of Psychology, Cardiff University, Cardiff, Wales.
1997-1999 Postdoctoral Research Associate, School of Psychology, University of St Andrews, St Andrews, Fife, Scotland.
1994-1997 PhD
1992-1993 Research Assistant, Department of Medicine, Austin and Repatriation Medical Centre, Austin Campus, University of Melbourne, Victoria, Australia.
1989-1991 Research Assistant, Departments of Neurology and Medicine, Clinical Pharmacology and Therapeutics Unit, Austin and Repatriation Medical Centre, Austin Campus, University of Melbourne, Victoria, Australia.
Research Funding (current)
Parkinson’s Disease Society, UK, The renin-angiotensin system – a novel concept for brain dopaminergic modification. Implications for Parkinson’s Disease. Dr. T. Jenkins, 2006-2007, £10000.
Research Funding (past, selected)
Merck, Sharp and Dohm Australia, Development of small molecules inhibitors of IRAP - potential use in the treatment of memory disorders.
S.Y. Chai, A.L. Albiston, T.A. Jenkins, F.A.O. Mendelsohn, M.W. Parker, H.L. Ng, 2004-2005, £45000.
Research Collaborations
Within QUB, I collaborate with Prof Gavin Reynolds. Externally, I have successful collaborations with Prof John Aggleton, Cardiff University and Dr Siew Yeen Chai, Howard Florey Institute, Australia.
Measures of esteem
Denis Wade Johnson & Johnson Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Investigators Award, 2004
Invited lectures at Department of Pharmacology, University of New South Wales, Australia, (2005); 8th World Congress on Clinical Pharmacology and Therapeutics, Brisbane, Australia, (2004); Cardiff University (2004); Bristol University (2004) and Merck Research Labs, Harlow. (2003).
Reviewed for the following funding organizations: The Medical Research Council and National Health and Medical Research Council of Australia.
Neurochemistry representative on Howard Florey Institute Internal Communication Committee, 2003-2005.
Postdoctoral representative for School of Psychology Focus Group for the People and Quality Research Team, Cardiff University, 2002.
Personal licence holder member of St Andrews University Animal Welfare Committee, 1999-2000.
Reviewed for Journal of Neuroscience, Journal of Neurochemistry, Neurobiology of Learning and Memory and Neuroscience.
Societies
Member of the Society for Neuroscience, International Society for Neurochemistry, European Brain and Behaviour Society, British Neuroscience Association, and British Association of Psychopharmacology.
Selected Original publications (out of 22 peer-reviewed articles and 4 book chapters)
Jenkins, T.A. and Chai, S.Y. (2006) Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats. Neurobiology of Learning and Memory, (in press).
Jenkins, T.A., Amin, E., Brown, M.W. and Aggleton, J.P. (2006) Changes in immediate early gene expression in the rat brain after unilateral lesions of the hippocampus. Neuroscience, 137, 747-759.
Ainge, J.A., Jenkins, T.A. and Winn, P. (2004) Induction of c-fos in specific thalamic nuclei following stimulation of the pedunculopontine tegmental nucleus. European Journal of Neuroscience, 70, 1827-1837.
Jenkins, T.A., Vann, S.D., Amin, E. and Aggleton, J.P. (2004) Anterior thalamic lesions stop immediate early gene activation in selective laminae of the retrosplenial cortex: evidence of covert pathology in rats. European Journal of Neuroscience, 19, 3291-3304.
Jenkins, T.A., Amin, E., Pearce, J.P., Brown, M.W. and Aggleton, J.P. (2004) Novel spatial arrangements of familiar visual stimuli promote activity in the rat hippocampal formation but not the parahippocampal cortices: A c-fos expression study. Neuroscience, 124, 43-52.
Chai, S.Y., Fernando, R., Ye, S., Peck, G., Mendelsohn, F.A.O., Jenkins, T.A. and Albiston, A.L. (2004) The angiotensin IV/AT4 receptor. In ‘What’s new in the renin-angiotensin system?’ Cellular and Molecular Life Sciences, 61, 2728-37.
Zheng, Y., Pearce J.M., Vann S.D., Good M., Jenkins T.A., Smith P.F. and Aggleton, J.P. (2003) Using idiothetic cues to swim a path with a fixed trajectory and distance: Necessary involvement of the hippocampus but not the retrosplenial cortex. Behavioral Neuroscience, 117, 1363-1377.
Jenkins, T.A., Amin, E., Harold, G.T., Pearce, J.M. and Aggleton, J.P. (2003) Different patterns of hippocampal formation activity associated with different spatial tasks: a Fos imaging study in rats. Experimental Brain Research, 151, 514-523.
Jenkins, T.A., Dias, R., Amin, E. and Aggleton, J.P. (2002) Changes in Fos expression in the rat brain after unilateral lesions of the anterior thalamic nuclei. European Journal of Neuroscience, 16, 1425-1432.
Jenkins, T.A., Dias, R., Amin, E., Brown, M.W. and Aggleton, J.P. (2002) Fos imaging reveals that lesions of the anterior thalamic nuclei produce widespread limbic hypoactivity in rats. Journal of Neuroscience, 22, 5230-5238.
Jenkins, T.A., Wong, J.Y.F., Howells, D.W., Mendelsohn, F.A.O. and Chai, S.Y. (1999) Effect of chronic angiotensin converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse. Journal of Neurochemistry, 73(1), 214-219.
Jenkins, T.A., Mendelsohn, F.A.O. and Chai, S.Y. (1997) Angiotensin converting enzyme modulates dopamine turnover in the striatum. Journal of Neurochemistry, 68(3), 1304-1311.